Clinical Trials Browser

Brain Neoplasms

Anatomic Stage III Breast Cancer AJCC v8

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Polycystic Ovary Syndrome

Breast Neoplasms

Breast Neoplasms

Locoregional Recurrence

Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer

Breast Neoplasms

Breast Neoplasms

Endometrial Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Cancer Female

Carcinoma, Intraductal, Noninfiltrating

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Endometrial Neoplasms

Breast Neoplasms

Carcinoma, Intraductal, Noninfiltrating

Breast Neoplasms

Breast Carcinoma In Situ

Polycystic Ovary Syndrome

Breast Neoplasms

Advanced Breast Cancer

Breast Neoplasms

Advanced Breast Carcinoma

Breast Neoplasms

Breast Neoplasms

Endometrial Stromal Tumors

Breast Neoplasms

Breast Neoplasms

Endometrial Neoplasms

Endometrial Neoplasms

Breast Neoplasms

Low-Grade Serous Ovarian Cancer

Advanced Breast Cancer

Carcinoma, Ductal

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Cancer Female

Breast Neoplasms

Breast Neoplasms

Clinical Trials

Study of Letrozole in Recurrent Gliomas

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients

DEBRA

PHACS

OXYTAM

MIRHO

A Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth in Women With PCOS

Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

RaPhLRR

LaPemERLA

ADEPT

Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer

EndoMAP

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

MNEMOSYNE

NeoMARS

Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

I-SPY

FEMUS

CARABELA

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

FELINE

LoTam

PCOS OID

MECCA

Emulation of the MONARCH-3 Trial Using Specialty Oncology Electronic Health Records Databases

Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

POWER II

NELOPHER

BFR-ESS

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

PATINA

A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma

ALPINE: Maintenance Letrozole/Abemaciclib

Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer

PLUM

CHAMELEON

Emulation of the PALOMA-2 Trial

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer

CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)

NAOMI

TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer

POETIC-A

Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer